BR112021017950A2 - Bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres - Google Patents

Bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres

Info

Publication number
BR112021017950A2
BR112021017950A2 BR112021017950A BR112021017950A BR112021017950A2 BR 112021017950 A2 BR112021017950 A2 BR 112021017950A2 BR 112021017950 A BR112021017950 A BR 112021017950A BR 112021017950 A BR112021017950 A BR 112021017950A BR 112021017950 A2 BR112021017950 A2 BR 112021017950A2
Authority
BR
Brazil
Prior art keywords
inflammatory diseases
cancers
prevention
treatment
bacteria
Prior art date
Application number
BR112021017950A
Other languages
English (en)
Inventor
Muriel Dominique Mathilde Kropp Camille
Frédéric Elustondo
Georges Rawadi
Nicole Lecorf Katy
Laure Rinaldi
Sophie Madeleine Soto Marion
Patrizia Brigidi
Philippe Langella
Martin Rosique Rebeca
Paule Claus Sandrine
Original Assignee
Univ Bologna Alma Mater Studiorum
Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement
Ysopia Biosciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1902437A external-priority patent/FR3093642A1/fr
Priority claimed from FR1908384A external-priority patent/FR3099054A1/fr
Application filed by Univ Bologna Alma Mater Studiorum, Institut National De Rech Pour Lagriculture Lalimentation Et Lenvironnement, Ysopia Biosciences filed Critical Univ Bologna Alma Mater Studiorum
Publication of BR112021017950A2 publication Critical patent/BR112021017950A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/74—Undefined extracts from fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres. a invenção refere-se a uma bactéria da família christensenellaceae, em particular do gênero christensenella, ou uma composição contendo a mesma para uso na prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou cânceres em humanos ou animais.
BR112021017950A 2019-03-11 2020-03-11 Bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres BR112021017950A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962816539P 2019-03-11 2019-03-11
FR1902437A FR3093642A1 (fr) 2019-03-11 2019-03-11 Bactérie de la famille des Christensenellacées dans la prévention et/ou le traitement de maladies inflammatoires chroniques et/ou de cancers
FR1908384A FR3099054A1 (fr) 2019-07-24 2019-07-24 Souche de Christensenella pour son utilisation dans le traitement et la prévention d’une inflammation gastro-intestinale
PCT/EP2020/056565 WO2020182916A1 (fr) 2019-03-11 2020-03-11 Bacterie de la famille des christensenellacées dans la prevention et/ou le traitement de maladies inflammatoires chroniques et/ou de maladies gastro-intestinales inflammatoires et/ou de cancers

Publications (1)

Publication Number Publication Date
BR112021017950A2 true BR112021017950A2 (pt) 2021-11-16

Family

ID=70110267

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021017950A BR112021017950A2 (pt) 2019-03-11 2020-03-11 Bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres

Country Status (7)

Country Link
US (1) US20230167401A1 (pt)
EP (1) EP3937958A1 (pt)
JP (1) JP2022525058A (pt)
BR (1) BR112021017950A2 (pt)
IL (1) IL286182A (pt)
MX (1) MX2021010868A (pt)
WO (1) WO2020182916A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3114106A1 (fr) * 2020-09-16 2022-03-18 Lnc Therapeutics Souche bactérienne appartenant au genre Christensenella et compositions
CN112933115B (zh) * 2020-12-31 2023-01-31 江南大学 Akkermansia muciniphila在治疗慢性胰腺炎方面的应用
JP2024506052A (ja) * 2021-02-08 2024-02-08 リスキュア・バイオサイエンシーズ・カンパニー・リミテッド ロイコノストック・シトレウム菌株を有効成分として含む胆汁うっ滞性肝疾患の予防または治療用医薬組成物
CN112940974A (zh) * 2021-02-24 2021-06-11 四川农业大学 一种可培养厌氧菌株与猪肠上皮细胞共培养方法
CN113151070B (zh) * 2021-04-02 2022-09-06 江南大学 一株可提高肠道中克里斯藤森菌科相对丰度的发酵乳杆菌
AU2021439233A1 (en) * 2021-04-06 2023-11-23 Moon (guangzhou) Biotech Co., Ltd. Bacterial strain, composition, drug for use in combination and use
CN113069475B (zh) * 2021-04-06 2023-06-02 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物和用途
CN117065006A (zh) * 2021-04-06 2023-11-17 慕恩（广州）生物科技有限公司 包含微生物和降糖降脂药物的联用药物
FR3126990B1 (fr) * 2021-09-14 2023-09-22 Ysopia Biosciences Milieu de culture adapté aux bactéries de l’espèce Christensenella minuta
FR3126991A1 (fr) * 2021-09-16 2023-03-17 Ysopia Biosciences Souche bactérienne dans la prévention et/ou le traitement de pathologies inflammatoires
CN113975301B (zh) * 2021-11-24 2023-06-30 暨南大学 一种用于提高精子活力的益生菌制剂及其用途
CN114159477B (zh) * 2021-11-24 2023-06-30 暨南大学 一种用于改善肠炎诱发的男性生殖损伤的益生菌制剂及其用途
CN114259507B (zh) * 2021-12-27 2022-09-16 暨南大学 一种小克里斯滕森氏菌在制备治疗和/或预防高尿酸相关疾病的药物中的应用
CN116925975B (zh) * 2023-08-18 2024-01-23 善恩康生物科技（苏州）有限公司 一种Akkermansia muciniphila及其产品和应用
CN116919994B (zh) * 2023-09-15 2023-12-08 中国农业大学 小克里斯滕森氏菌在制备治疗多囊卵巢综合征的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10206958B2 (en) * 2014-04-23 2019-02-19 Cornell University Modulation of fat storage in a subject by altering population levels of christensenellaceae in the GI tract
WO2016156527A1 (fr) 2015-03-31 2016-10-06 International Nutrition Research Company Composition pour le traitement d'un etat metabolique pathogene du microbiote intestinal et des maladies derivees
FR3063646B1 (fr) 2017-03-10 2021-07-30 International Nutrition Res Company Bacteries specifiques pour leur utilisation comme medicament en particulier pour lutter contre le surpoids, l'obesite, les maladies cardiometaboliques et les maladies inflammatoires de l'intestin

Also Published As

Publication number Publication date
WO2020182916A1 (fr) 2020-09-17
JP2022525058A (ja) 2022-05-11
MX2021010868A (es) 2022-03-25
EP3937958A1 (fr) 2022-01-19
IL286182A (en) 2021-10-31
US20230167401A1 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
BR112021017950A2 (pt) Bactéria da família christensenellaceae para prevenção e/ou tratamento de doenças inflamatórias crônicas e/ou doenças inflamatórias gastrointestinais e/ou cânceres
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1125136T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
CY1122148T1 (el) Συνθεσεις που περιεχουν βακτηριακα στελεχη
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
CY1125659T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CY1121473T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
MA41013B1 (fr) Compositions comprenant des souches bactériennes
BR112018014654A2 (pt) cepa inovadora de bactérias probióticas e composições e usos da mesma
BR112018015121A2 (pt) cepa bacteriana da espécie faecalibacterium prausnitzii cncm i-4573 para o tratamento e a prevenção da inflamação gastrointestinal
MD3768284T2 (ro) Compoziţii de entrecoccus flagellin pentru utilizare în terapie
EA201990551A1 (ru) Антибиотические соединения
BR112015011697A2 (pt) antibióticos macrocíclicos de amplo espectro
BR112017019413A2 (pt) combinação de agente bactericida com um agente alcalinizante lisossomotrópico para o tratamento de uma infecção bacteriana
EA202091118A1 (ru) Антибактериальные соединения
MX2020012800A (es) Cannabinoides y usos de los mismos.
BR112021025732A2 (pt) Inibidores macrocíclicos de mcl-1
NI202000052A (es) Terapia de combinación para tratar o prevenir el cáncer
MX2018000092A (es) Nuevo lipolantipeptido biciclico, preparacion y uso como agente antimicrobiano.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
BR112022010411A2 (pt) Composições bacterianas projetadas e usos das mesmas
IT201900020654A1 (it) Frazioni di olio di pistacia lentiscus e loro uso nel trattamento o nella prevenzione di infezioni del cavo orale ed otorinolaringoiatriche sostenute da batteri gram-positivi o gram-negativi
BR112017022796A2 (pt) composições antibacterianas e métodos
EA202092204A1 (ru) Композиции

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]